An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia

被引:44
|
作者
Chiriaco, G. [1 ]
Cauci, S. [2 ]
Mazzon, G. [1 ]
Trombetta, C. [1 ]
机构
[1] Univ Trieste, Urol Hosp Dept, Dept Med Surg & Hlth Sci, Trieste, Italy
[2] Univ Udine, Sch Med, Dept Med & Biol Sci, I-33100 Udine, Italy
关键词
5-alpha-reductase inhibitor; AGA; benign prostatic hyperplasia; erectile dysfunction; finasteride safety; finasteride side effects; follicle stimulating hormone; free testosterone; loss of libido; luteinizing hormone; male pattern hair loss; PFS; Post-finasteride syndrome; sexual dysfunction; testosterone; BENIGN PROSTATIC HYPERPLASIA; 5-ALPHA-REDUCTASE INHIBITORS; ERECTILE DYSFUNCTION; POST-FINASTERIDE; THERAPY; TESTOSTERONE; SAFETY; EXPERIENCE; EFFICACY; SCALE;
D O I
10.1111/andr.12147
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Concern regarding adverse effects of finasteride is increasing. We aimed to determine the type and frequency of symptoms in men having long-term sexual and non-sexual side effects after finasteride treatment (a condition recently called post-finasteride syndrome, PFS) against androgenetic alopecia (AGA). Subjects were recruited at the Urology Unit of the Trieste University-Hospital, and from a dedicated website. Out of 79 participants, 34% were white Italians, mean age was 33.4 +/- 7.60years, mean duration of finasteride use was 27.3 +/- 33.21months; mean time from finasteride discontinuation was 44.1 +/- 34.20months. Symptoms were investigated by an ad hoc 100 questions' questionnaire, and by validated Arizona Sexual Experience Scale (ASEX) and Aging Male Symptom Scale (AMS) questionnaires. By ASEX questionnaire, 40.5% of participants declared getting and keeping erection very difficult, and 3.8% never achieved; reaching orgasm was declared very difficult by 16.5%, and never achieved by 2.5%. By the ad hoc questionnaire, the most frequent sexual symptoms referred were loss of penis sensitivity (87.3%), decreased ejaculatory force (82.3%), and low penile temperature (78.5%). The most frequent non-sexual symptoms were reduced feeling of life pleasure or emotions (anhedonia) (75.9%); lack of mental concentration (72.2%), and loss of muscle tone/mass (51.9%). We contributed to inform about symptoms of PFS patients; unexpectedly loss of penis sensitivity was more frequent than severe erectile dysfunction and loss of muscle tone/mass was affecting half of the subjects. Further studies are necessary to investigate the pathophysiological and biochemical pathways leading to the post-finasteride syndrome.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 50 条
  • [1] Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system
    Shin, Jung-Won
    Chung, Euy-Hyun
    Kim, Moon-Bum
    Kim, Tae-Ook
    Kim, Woo-Il
    Huh, Chang-Hun
    [J]. JOURNAL OF DERMATOLOGY, 2019, 46 (02): : 139 - 143
  • [2] Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia
    Kaufman, KD
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2002, 12 (01) : 38 - 49
  • [3] Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase
    Nguyen, David-Dan
    Herzog, Peter
    Cone, Eugene B.
    Labban, Muhieddine
    Zorn, Kevin C.
    Chughtai, Bilal
    Basaria, Shehzad
    Elterman, Dean S.
    Quoc-Dien Trinh
    Bhojani, Naeem
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (01) : 179 - 181
  • [4] Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
    Khera, Mohit
    Than, Jeffrey K.
    Anaissie, James
    Antar, Ali
    Song, Weitao
    Losso, Boriss
    Pastuszak, Alexander
    Kohn, Taylor
    Mirabal, Jorge Rivera
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 1201 - 1209
  • [5] Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss)
    Kaufman, Keith D.
    Rotonda, Jennifer
    Shah, Arvind K.
    Meehan, Alan G.
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2008, 18 (04) : 400 - 406
  • [6] Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia
    Cauci, Sabina
    Chiriaco, Giovanni
    Cecchin, Erika
    Toffoli, Giuseppe
    Xodo, Serena
    Stinco, Giuseppe
    Trombetta, Carlo
    [J]. SEXUAL MEDICINE, 2017, 5 (01): : E61 - E71
  • [7] Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
    Di Loreto, Carla
    La Marra, Francesco
    Mazzon, Giorgio
    Belgrano, Emanuele
    Trombetta, Carlo
    Cauci, Sabina
    [J]. PLOS ONE, 2014, 9 (06):
  • [8] Endocrine Adverse Effects of Long-Term Opioid Use
    Bogler, Orly
    Incze, Michael A.
    [J]. JAMA INTERNAL MEDICINE, 2024, 184 (07) : 831 - 832
  • [9] EVALUATION OF ADVERSE-EFFECTS OF LONG-TERM HYPOSENSITIZATION
    LEVINSON, AI
    SUMMERS, RJ
    LAWLEY, TJ
    EVANS, R
    FRANK, MM
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1978, 62 (02) : 109 - 114
  • [10] RETROSPECTIVE CURRICULUM EVALUATION - AN APPROACH TO THE EVALUATION OF LONG-TERM EFFECTS
    TAMIR, P
    AMIR, R
    [J]. CURRICULUM INQUIRY, 1981, 11 (03) : 259 - 278